Pages

Wednesday, September 13, 2017

IACP submits comments to Florida State Board of Pharmacy opposing amendment clarifying that the compounding of human products (sterile and nonsterile) for office-use must be in compliance with 21 USC 353b, including being registered as an outsourcing facility.